Get started
Author

О. І. Vynnychenko

Observed names: O. I. Vynnychenko, O. Vynnychenko, O. І. Vynnychenko, O.I. Vynnychenko, Oleksandr I. Vynnychenko, Oleksandr Vynnychenko, Vynnychenko, Oleksandr Ihorovych, О.І. Винниченко
Observed institution: Sumy State University
ORCID: 0000-0001-5651-0323
Observed ORCID: 0000-0001-5651-0323
OpenAlex ID: A5055122071
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
2023 · Shukui Qin, Stephen L Chan, et al. · The Lancet · 798
Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised study
2025 · Shun Lu, Oleksandr Vynnychenko, et al. · The Lancet Respiratory Medicine · 5
Prognostic impact of body mass index on metastatic HER2-positive breast cancer survival
2024 · O.I. Vynnychenko, Y.V. Moskalenko · Український радіологічний та онкологічний журнал · 5
PDF
Genetic alterations affect immune contexture of non-small cell lung cancer: Ukrainian study
2025 · Denys Kozakov, Nazarii Kobyliak, et al. · Frontiers in Medicine · 3
PDF
The Role of Next-generation Sequencing in Lung Cancer Diagnosis
2023 · Julia Moskalenko, Oleksandr Vynnychenko, et al. · Eastern Ukrainian Medical Journal · 3
PDF
Lung Cancer Prevalence: From Local to Global
2021 · О. М. Smorodska, Yl. V. Moskalenko, et al. · Art of Medicine · 2
The role of PIK3CA mutations in the development of breast cancer (a literature review)
2020 · A. O. Pryvalova, I. O. Vynnychenko, et al. · Zaporozhye Medical Journal · 2
PDF
Бульозний пемфігоїд Левера у хворого на метастатичний рак легені після лікування атезолізумабом
2019 · Медичний інститут Сумського державного університету, Суми, І.О. Винниченко, et al. · Clinical Oncology · 2
Lung Cancer in Ukraine
2025 · Oleksandr I. Vynnychenko, Roman A. Moskalenko, et al. · Clinical and Preventive Medicine · 1
PDF
Distribution of M1 and M2 macrophages and their impact on survival in non-small cell lung cancer
2025 · O. I. Vynnychenko, Yu. V. Moskalenko, et al. · Reports of Morphology · 1
A single-center, cohort study of the mutational profile of Ukrainian patients with non-small cell lung cancer
2024 · O.I. Vynnychenko, Y.V. Moskalenko, et al. · Український радіологічний та онкологічний журнал · 1
PDF
627MO POD1UM-304: Phase III study of retifanlimab plus platinum-based chemotherapy (Chemo) as first-line (1L) therapy for nonsquamous or squamous metastatic non–small cell lung cancer (mNSCLC)
2024 · S. Lu, O. Vynnychenko, et al. · Annals of Oncology · 1
Prognostic role of STAT6 in patients with non-small cell lung cancer
2024 · O. Vynnychenko, Y. Moskalenko, et al. · Regulatory Mechanisms in Biosystems · 1
PDF
Молекулярні біомаркери в менеджменті пацієнтів з недрібноклітинним раком легень
2024 · O. Sulaieva, O. Pototska, et al. · Practical oncology · 1
Modern vector in treatment of patients with lung cancer: tyrosine kinase inhibitors in epidermal growth factor receptor mutations (literature review)
2021 · O.M. Smorodska, Yu.V. Moskalenko, et al. · Medicni perspektivi · 1
PDF
MO01.42 Myelopreservation with Trilaciclib Regardless of Risk of Chemotherapy-Induced Febrile Neutropenia and/or Anemia or Red Blood Cell Transfusions
2021 · M. Hussein, T.A. Gersten, et al. · Journal of Thoracic Oncology · 1
PDF
Case Report of Giant Nonmetastatic Gastrointestinal Solid Tumor without Clinical Manifestations in a Middle-Aged Male Patient
2020 · I. Vynnychenko, M. Kononenko, et al. · Novosti hirurgii · 1
PDF
Analysis of the Incidence Rate of Colorectal Cancer Among Residents of the Sumy Region
2020 · V.V. Kostiuchenko, Y.V. Moskalenko, et al. · Eastern Ukrainian Medical Journal · 1
PDF
PD-L1 testing as a way of personalizing the treatment of non-small cell lung cancer
2019 · Yu. V. Moskalenko, I. О. Vуnnуchenko, et al. · Likarska sprava · 1
Prognostic Significance of Foxp3 in Radically Treated Non-small Cell Lung Cancer Patients
2025 · O. I. Vynnychenko, Y. V. Moskalenko, et al. · Art of Medicine
PDF
STAT6 as a biomarker of trastuzumab resistance in patients with metastatic HER2-positive breast cancer
2025 · O.I. Vynnychenko, Yu.V. Moskalenko, et al. · Український радіологічний та онкологічний журнал
PDF
Markers of inflammation as predictors of efficacy of trastuzumab therapy in HER2-positive metastatic breast cancer patients
2025 · O. Vynnychenko, Y. Moskalenko, et al. · Regulatory Mechanisms in Biosystems
PDF
Prognostic Significance of Tr53 Gene Mutation in Patients With Metastatic Her2-positive Breast Cancer
2025 · O. I. Vynnychenko, Y. V. Moskalenko, et al. · Art of Medicine
PDF
The Role of Tp53 Gene Mutation in the Survival of Non-small Cell Lung Cancer Patients
2025 · Oleksandr Vynnychenko, Yuliia Moskalenko, et al. · Eastern Ukrainian Medical Journal
PDF
The Impact of Body Mass Index on the Risk of Developing Serious Adverse Events in Patients With Metastatic Non-small Cell Lung Cancer
2025 · O. I. Vynnychenko, R. A. Moskalenko
PDF
Works count: 40
Citation count: 831
H-index: 3
I10-index: 1
Year
Topic
Type